INTERSECT ENT, INC.

XENTUnited States

28 filed reports · 354 financial concepts

Latest figures

Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.

Latest fiscal year

Revenue

$107M

FY2021 · to Dec 31, 2021

up +32.5% vs $80.6M

10-K

Net income

-$160M

FY2021 · to Dec 31, 2021

a year earlier: -$72.3M

10-K

Operating income

-$141M

FY2021 · to Dec 31, 2021

a year earlier: -$67.7M

10-K

Latest quarter

Revenue

$21.6M

Q1 FY2022 · to Mar 31, 2022

down −11.3% vs $24.3M

10-Q

Net income

-$28.8M

Q1 FY2022 · to Mar 31, 2022

a year earlier: -$20M

10-Q

Operating income

-$26.7M

Q1 FY2022 · to Mar 31, 2022

a year earlier: -$18.6M

10-Q

Filed reports

28 reports · Jun 2015 to Mar 2022

Each report counts once it has at least one extracted financial fact.

Report typeReportsFactsPeriods
Quarterly · 10-QSEC EDGAR212,156Jun 2015 to Mar 2022
Annual · 10-KSEC EDGAR72,470Dec 2015 to Dec 2021

Documents

PeriodTypePeriod endPublishedFactsSource
FY2022 Q110-Q2022-03-312022-05-04276Open
FY202110-K2021-12-312022-03-08658Open
FY2021 Q310-Q2021-09-302021-11-02185Open
FY2021 Q210-Q2021-06-302021-08-06163Open
FY2021 Q110-Q2021-03-312021-05-10109Open
FY202010-K2020-12-312021-03-09303Open
FY2020 Q310-Q2020-09-302020-11-02101Open
FY2020 Q210-Q2020-06-302020-08-05128Open
FY2020 Q110-Q2020-03-312020-05-1184Open
FY201910-K2019-12-312020-02-27327Open
FY2019 Q310-Q2019-09-302019-11-05106Open
FY2019 Q210-Q2019-06-302019-08-0584Open

Financial data

354 concepts · 4,626 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial352 concepts · 4,555 facts · Jan 2013 to Mar 2022

  • Cost of revenue (US GAAP)43 · Dec 2013 to Mar 2022
  • Gross profit (US GAAP)43 · Dec 2013 to Mar 2022
  • Net income loss43 · Dec 2013 to Mar 2022
  • Operating expenses (US GAAP)43 · Dec 2013 to Mar 2022
  • Operating income loss43 · Dec 2013 to Mar 2022
  • Research and development expense43 · Dec 2013 to Mar 2022
  • Revenue43 · Dec 2013 to Mar 2022
  • Selling general and administrative expense43 · Dec 2013 to Mar 2022
  • Cash and cash equivalents at carrying value42 · Dec 2013 to Mar 2022
  • Comprehensive income net of tax42 · Dec 2013 to Mar 2022
  • Depreciation and amortization42 · Dec 2013 to Mar 2022
  • Increase decrease in accounts payable40 · Dec 2013 to Mar 2022
  • Increase decrease in accounts receivable40 · Dec 2013 to Mar 2022
  • Increase decrease in employee related liabilities40 · Dec 2013 to Mar 2022
  • Increase decrease in inventories40 · Dec 2013 to Mar 2022
  • Increase decrease in other operating liabilities40 · Dec 2013 to Mar 2022
  • Increase decrease in prepaid expenses other40 · Dec 2013 to Mar 2022
  • Payments to acquire property plant and equipment40 · Dec 2013 to Mar 2022
  • Proceeds from issuance of common stock40 · Dec 2013 to Mar 2022
  • Stockholders equity (US GAAP)39 · Dec 2013 to Mar 2022
  • Earnings per share basic and diluted38 · Dec 2013 to Dec 2021
  • Payments to acquire short term investments38 · Dec 2014 to Mar 2022
  • Weighted average number of share outstanding basic and diluted38 · Dec 2013 to Dec 2021
  • Accounts payable current37 · Dec 2014 to Mar 2022

Product1 concept · 46 facts · Dec 2018 to Mar 2022

  • Revenue46 · Dec 2018 to Mar 2022

Segment1 concept · 25 facts · Dec 2017 to Jun 2020

  • Revenue25 · Dec 2017 to Jun 2020

Segments

71 facts

Figures broken down by business line, region, product or another axis the company reports on.

Product or service5 members · 46 facts

  • PROPEL Family of Products [Member]15 · Dec 2018 to Mar 2022
  • SINUVA15 · Dec 2018 to Mar 2022
  • VENSURE, CUBE, and accessories13 · Dec 2018 to Mar 2022
  • CUBE2 · Mar 2021 to Jun 2021
  • PROPEL And PROPEL Mini1 · Mar 2021

Statement business segments2 members · 25 facts

  • PROPEL Family of Products [Member]13 · Dec 2017 to Jun 2020
  • SINUVA12 · Mar 2018 to Jun 2020

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

No commentary or risk-factor text for this company.

Earnings calls

Transcripts with management claims and analyst questions, one per fiscal period.

No earnings-call transcripts for this company.

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Ask about this company in your AI model

Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.

Use FactIQ to get the revenue, net income and operating income of INTERSECT ENT, INC. (XENT) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.

Works once FactIQ is connected

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 19, 2026) and refreshed every few hours.